Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 33 for “"CDKN2B"”.
-
Evaluation of targeted methylation at the CDKN2B promoter
… network. The gene selected for this study was CDKN2B, a cell cycle regulating tumour suppressor gene strongly implicated in Myelodysplastic Syndrome - MDS and Acute Myeloid Leukaemia - AML. Site-biased zinc finger: DNA methyltransferase fusion proteins were specifically designed with the aim of …
-
Μελέτη του ρόλου των μεταλλαγών στα γονίδια p14ARF, p15INK4b και p16INK4a και της γενωμικής αστάθειας στην ακτινική υπερκεράτωση
… We investigated the involvement of the CDKN2A, CDKN2B and p53 genes in AK and in the progression of AK to SCC. Mutational analysis on exons 1a, 1b and 2 of the CDKN2A locus and exon 1 of the CDKN2B locus as well as allelic imbalance was performed in 26 AK specimens. Expression levels of the …
-
Molecular characterisation of renal cell carcinoma and related disorders
… exome sequencing of familial RCC kindreds, \(CDKN2B\) was identified as a novel familial RCC gene. The role of \(CDKN2B\) mutations in neoplasia was evaluated in familial and sporadic RCC and phaeochromocytoma. \(In\) \(vitro\) assays confirmed that germline \(CDKN2B\) mutations associated …
-
Cambios epigenéticos, génicos y de expresión proteica en el cáncer de laringe. Análisis del segmento cromosómico 9P21
… tumores, centrando nuestro estudio en CDKN2A y CDKN2B, localizados en el segmento cromosómico 9p21. 2. Analizar la expresión de las proteínas p15 y p16. 3. Relacionar el patrón de metilación con la expresión proteica. 4. Relacionar el patrón de metilación y la expresión proteica con los aspectos …
-
Identification and Functional Characterization of Causative DNA Sequence Variants in Genetic Risk Loci of Periodontitis
… with DNA, RNA and proteins. Among them, lncRNA CDKN2B-AS1 was identified as a genetic suscep-tibility locus associated with a variety of complex diseases, such as myocardial infarc-tion (MI), coronary artery disease (CAD), and severe periodontitis. However, despite a large number of studies …
-
Die Rolle des Enhancer Zeste Homologs 2 im malignen Melanom
… Durch Analyse von Transkriptomdaten wurden CDKN2B, TIMP3 und VASH1 als potentielle Zielgene von EZH2 identifiziert, deren mRNA-Expression invers mit der von EZH2 korrelieren. Nach Hemmung der EZH2-Expression wurde zudem bei CDKN2B, TIMP3 und VASH1 eine gesteigerte mRNA-Expression beobachtet. …
-
Dissecting mechanisms involved in the aetiological overlap between Type 2 diabetes and cancer
… on chromosome 10 and the <em>CDKN2A</em> and <em>CDKN2B</em> locus at chromosome 9p21 (Chr9p21). PTEN is known to negatively regulate the phosphatidylinositol-3-kinase/AKT (PI3K-AKT) pathway which mediates many of the metabolic downstream effects of insulin signalling. Rodent data supports a role …
-
Elucidation of the chondrogenic program using a combination of biology and technology
… in an ∼ 18 fold increase in the expression of Cdkn2b — a cyclin dependent kinase inhibitor. SiRNA knockdown of Cdkn2b resulted in sustained mesenchymal proliferation. Further, we determined that FGF4 regulates Cdkn2b through a MEKI/ERK-dependent pathway. Additionally, we show that FGF4 promotes …
-
DNA-Methylierungssignaturen bei älteren Patienten mit akuter myeloischer Leukämie
… untersucht: DAPK1, CEBPA, RARB2, CDKN2B und ESR. Mittels Pyrosequenzierung wurden hochauflösende quantitative Methylierungsanalysen mit hohem Probendurchsatz an insgesamt 111 CpG-Dinukleotiden durchgeführt. <br>In der Promotorregion des Proteinkinasegens DAPK1 konnte - bei bisher …
-
Gene-specific demethylation and re-activation of tumor suppressors in acute myeloid leukemia via a novel RNA-mediated platform
… at the CDK inhibitor and tumor suppressor gene CDKN2B. Currently available demethylating agents, namely 5-azacytidine and 5-aza-2’-deoxycytidine, are used to treat acute myeloid leukemia and inhibit DNA methyltransferases either by direct binding or by incorporation into DNA as nucleoside …
-
Characterisation of the long non-coding RNA ANRIL in human melanoma
… is transcribed from a gene, antisense to the CDKN2B locus, that encompasses multiple disease-associated polymorphisms. Divergent reports have suggested both concordant and discordant expression of ANRIL and CDKN2A or CDKN2B in different tissues and cell types. In view of these conflicting …
-
Genome-wide Analysis of Copy Number Aberrations in Canine Osteosarcoma
… genes, cyclin-dependent kinase inhibitor 2B (CDKN2B) and the membrane associated guanylate kinase, WW and PDZ domain containing 2 (MAGI2), which have not been previously identified in canine OSA and may have roles in driving OSA tumour progression. We also identified highly similar genomic …
-
The Role of SOX2 in Colon Cancer Progression
… correlation with mRNA levels of RBL2-HUMAN and CDKN2B genes, which serve as regulators of G0 and G1 respectively. SOX2 was shown to physically bind and to the promoter region of these two genes and enhance their transcription. Thus high SOX2 expression, up-regulates the expression of key cell …
-
The Genetics of Primary Open-Angle Glaucoma: A Complex Human Disease
… expression of selected POAG candidate genes (CDKN2B, CDKN2A, CDKN2B-AS, SIX6, SRBD1, ATOH, CAV1, CAV2, ELOVL5, and TMCO1) was evaluated. Most of these genes showed high expression values in the trabecular meshwork and cornea. ATOH was only found to be expressed in the fetal TM and, …
-
The Transcriptomic Effects of MicroRNA-29b-3p in Porcine Granulosa Cells
… may bind to the promoter regions of GLUL, CDKN2B, and NR2F2, but does not regulate NR2F2 transcription. We instead identified genes miR-29b may regulate via 3’ UTR repression. Through transcriptomic analysis, we found miR-29b reduces the expression of pro-proliferative genes. MiR-29b also …
-
FATTORI DI RISCHIO GENETICI NELLA MALATTIA DI ALZHEIMER E NELLA DEMENZA FRONTOTEMPORALE: STUDIO DI ASSOCIAZIONE DI GENI CANDIDATI POSIZIONALI E FUNZIONALI
… C/T and rs3217992 G/A, spanning CDKN2A and CDKN2B, and covering 100% gene variability, were analyzed. According to our data, CDKN2A and CDKN2B don’t likely act as risk factors for AD. Given the potential importance of kinesin KIF24, protein expressed in neurons and involved in axonal …
-
Identification of the genetic basis of multicentric tumourigenesis
… for mutations in \(TP53\), \(PTEN\) and \(CDKN2B\) but none were detected. MPMT individuals may receive negative genetic test results for a number of reasons, which are discussed. They include referral bias and MPMT cases from a population based registry were also analysed and compared with …
-
Frequência de polimorfismos nos genes IKZF1 e CDKN2A/2B e análise descritiva em participantes pediátricos com leucemia linfoblástica aguda: um estudo multicêntrico de prevalência de base hospitalar na cidade do Rio de Janeiro
… of polymorphisms in the IKZF1, CDKN2A and CDKN2B genes. We also constructed a healthy population based on African, Amerindian and European populations for comparison with the leukemic population. Results. We demonstrate that SNPs rs3731217, rs4132601 and rs11978267 are in Hardy-Weinberg …
-
Διερεύνηση των παθογενετικών μηχανισμών που διέπουν τις ποιοτικές ανωμαλίες των μυελικών μεσεγχυματικών προγονικών κυττάρων σε πάσχοντες από μυελοδυσπλαστικά σύνδρομα
… inhibitors CDKN1A (p21), CDKN2A (p16), and CDKN2B (p15), along with PARG1, whereas their mean telomere length was upregulated. MDS-derived MSCs exhibited impaired capacity to support normal CD34+ myeloid and erythroid colony formation. No signicant changes were observed between patients and …
-
Establishment and analysis of patient-specific Group 3 medulloblastoma mouse models
… to block tumorigenesis, through regulation of CDKN2B and CRABP1 expression. Interestingly, patient-specific SMARCA4T910M mutant is able to block wild- type SMARCA4 effects in a dominant-negative manner. Since SMARCA4 has an antagonistic relationship with histone methyltransferase EZH2, we used …
Page 1 of 2